Alana Panzenhagen
About me
I am a researcher with 10+ years of experience in molecular and computational biology. I published over 20 articles in peer-reviewed journals, 7 of them as first-author – 2.5 articles a year since I started as an undergraduate, with an average impact factor of 5.01 (JCR 2022). I also presented my work at more than 10 different conferences worldwide and have made an effort to always engage the general public to the extent that I could translate science to their everyday life and interests. I view it as my responsibility to give back to the community (both researchers and the lay public) by educating them and taking their input back to science.
Research
I started my career in preclinical and clinical biological psychiatry, transitioning between several types of analytical approaches, from genomics and transcriptomics to neuroimaging. Now, I aim towards yet another kind of high-dimensional data, the translatome.
Teaching
I have teaching experience at the undergraduate, medical residency, and postgraduate levels, I co-supervised 1 B.Sc., 4 M.D., and 1 M.Sc. thesis.
Articles
- Journal article: FOOD AND CHEMICAL TOXICOLOGY. 2024;191:114851
- Journal article: EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE. 2024;:1-9
- Article: TRENDS IN PSYCHIATRY AND PSYCHOTHERAPY. 2024
- Article: CHEMOSPHERE. 2024;351:141239
- Article: JOURNAL OF PSYCHIATRIC RESEARCH. 2024;169:341-346
- Journal article: EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2023;75:s141-s142
- Article: JOURNAL OF BIOLOGICAL CHEMISTRY. 2021;297(2):100979
- Article: TRENDS IN PSYCHIATRY AND PSYCHOTHERAPY. 2021;43(1):1-8
- Article: MUTATION RESEARCH-GENETIC TOXICOLOGY AND ENVIRONMENTAL MUTAGENESIS. 2020;858:503239
- Article: CHEMOSPHERE. 2020;244:125400
- Article: JOURNAL OF PSYCHIATRIC RESEARCH. 2017;95:269-275
All other publications
- Preprint: MEDRXIV. 2023
- Review: LAB ANIMAL. 2023;52(10):229-246
- Preprint: BIORXIV. 2022
- Review: EUROPEAN ARCHIVES OF PSYCHIATRY AND CLINICAL NEUROSCIENCE. 2022;272(8):1395-1411
- Conference publication: EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2022;63:E170
- Review: SYSTEMATIC REVIEWS. 2022;11(1):150
- Editorial comment: NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS. 2022;137:104641
- Conference publication: JOURNAL OF NEUROCHEMISTRY. 2022;162:95
- Review: FRONTIERS IN NEUROLOGY. 2022;13:923988
- Conference publication: EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2021;51:E153-E154
- Conference publication: BIOPHYSICAL REVIEWS. 2021;13(6):1397
- Conference publication: BIOPHYSICAL REVIEWS. 2021;13(6):1437-1438
- Review: PLOS ONE. 2021;16(4):e0250377
- Editorial comment: TRENDS IN PSYCHIATRY AND PSYCHOTHERAPY. 2020;42(3):221-222
- Letter: PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY. 2019;94:109617
- Review: NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS. 2019;100:166-179
- Conference publication: JOURNAL OF NEUROCHEMISTRY. 2019;150:123
- Conference publication: EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2019;29:S887-S888
- Conference publication: EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2019;29:S1000-S1001
- Conference publication: EUROPEAN NEUROPSYCHOPHARMACOLOGY. 2019;29:S823
- Review: BMJ OPEN SCIENCE. 2018;2(1):e000001
- Show more
Employments
- Postdoctoral Studies, Department of Oncology-Pathology, Karolinska Institutet, 2024-2026
Degrees and Education
- PhD, Biochemistry, Biochemistry, Federal University of Rio Grande do Sul, 2025
- BSc, Biological Sciences, Federal University of Rio Grande do Sul, 2019
Visiting research fellowships
- Bi-nationally Supervised Doctoral Degree - Visiting Researcher, Max Planck Institute of Psychiatry, Project: Robust clustering of MDD subtypes using structural MRI and symptom profiles with ENIGMA MDD, 2021-2023
Editorial work
- Trends in Psychiatry and Psychotherapy, Associate editor, 2022
Journal reviewing
- Frontiers in Psychiatry
- Neuroscience and Biobehavioral Reviews